UniProtKB - P00734 (THRB_HUMAN)
Protein
Prothrombin
Gene
F2
Organism
Homo sapiens (Human)
Status
Functioni
Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.1 Publication
Miscellaneous
Prothrombin is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin and factors Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin.
It is not known whether 1 or 2 smaller activation peptides, with additional cleavage after Arg-314, are released in natural blood clotting.
Thrombin can itself cleave the N-terminal fragment (fragment 1) of the prothrombin, prior to its activation by factor Xa.
The cleavage after Arg-198, observed in vitro, does not occur in plasma.
Catalytic activityi
Selective cleavage of Arg-|-Gly bonds in fibrinogen to form fibrin and release fibrinopeptides A and B.
Activity regulationi
Inhibited by SERPINA5.1 Publication
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Active sitei | 406 | Charge relay system | 1 | |
| Active sitei | 462 | Charge relay system | 1 | |
| Active sitei | 568 | Charge relay system | 1 |
GO - Molecular functioni
- calcium ion binding Source: InterPro
- enzyme activator activity Source: Ensembl
- growth factor activity Source: BHF-UCL
- heparin binding Source: UniProtKB
- lipopolysaccharide binding Source: UniProtKB
- serine-type endopeptidase activity Source: UniProtKB
- signaling receptor binding Source: UniProtKB
- thrombospondin receptor activity Source: BHF-UCL
GO - Biological processi
- acute-phase response Source: UniProtKB-KW
- antimicrobial humoral immune response mediated by antimicrobial peptide Source: UniProtKB
- blood coagulation Source: Reactome
- blood coagulation, intrinsic pathway Source: Reactome
- cell surface receptor signaling pathway Source: BHF-UCL
- cellular protein metabolic process Source: Reactome
- cytolysis by host of symbiont cells Source: UniProtKB
- ER to Golgi vesicle-mediated transport Source: Reactome
- fibrinolysis Source: UniProtKB
- G-protein coupled receptor signaling pathway Source: Reactome
- multicellular organism development Source: ProtInc
- negative regulation of astrocyte differentiation Source: BHF-UCL
- negative regulation of cytokine production involved in inflammatory response Source: UniProtKB
- negative regulation of fibrinolysis Source: BHF-UCL
- negative regulation of platelet activation Source: BHF-UCL
- negative regulation of proteolysis Source: BHF-UCL
- neutrophil mediated killing of gram-negative bacterium Source: UniProtKB
- platelet activation Source: BHF-UCL
- positive regulation of blood coagulation Source: BHF-UCL
- positive regulation of cell growth Source: Ensembl
- positive regulation of cell proliferation Source: Ensembl
- positive regulation of collagen biosynthetic process Source: BHF-UCL
- positive regulation of JAK-STAT cascade Source: BHF-UCL
- positive regulation of lipid kinase activity Source: BHF-UCL
- positive regulation of phosphatidylinositol 3-kinase signaling Source: Ensembl
- positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway Source: BHF-UCL
- positive regulation of protein localization to nucleus Source: BHF-UCL
- positive regulation of protein phosphorylation Source: BHF-UCL
- positive regulation of reactive oxygen species metabolic process Source: UniProtKB
- positive regulation of release of sequestered calcium ion into cytosol Source: BHF-UCL
- proteolysis Source: ProtInc
- regulation of blood coagulation Source: UniProtKB
- regulation of cell shape Source: Ensembl
- regulation of complement activation Source: Reactome
- regulation of cytosolic calcium ion concentration Source: BHF-UCL
- response to wounding Source: BHF-UCL
Keywordsi
| Molecular function | Hydrolase, Protease, Serine protease |
| Biological process | Acute phase, Blood coagulation, Hemostasis |
| Ligand | Calcium |
Enzyme and pathway databases
| BRENDAi | 3.4.21.5 2681 |
| Reactomei | R-HSA-140837 Intrinsic Pathway of Fibrin Clot Formation R-HSA-140875 Common Pathway of Fibrin Clot Formation R-HSA-159740 Gamma-carboxylation of protein precursors R-HSA-159763 Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159782 Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-202733 Cell surface interactions at the vascular wall R-HSA-375276 Peptide ligand-binding receptors R-HSA-381426 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-416476 G alpha (q) signalling events R-HSA-456926 Thrombin signalling through proteinase activated receptors (PARs) R-HSA-76009 Platelet Aggregation (Plug Formation) R-HSA-977606 Regulation of Complement cascade |
| SABIO-RKi | P00734 |
| SIGNORi | P00734 |
Protein family/group databases
| MEROPSi | S01.217 |
| MoonDBi | P00734 Curated |
Names & Taxonomyi
| Protein namesi | Recommended name: Prothrombin (EC:3.4.21.5)Alternative name(s): Coagulation factor II Cleaved into the following 4 chains: |
| Gene namesi | Name:F2 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| EuPathDBi | HostDB:ENSG00000180210.14 |
| HGNCi | HGNC:3535 F2 |
| MIMi | 176930 gene |
| neXtProti | NX_P00734 |
Pathology & Biotechi
Involvement in diseasei
Factor II deficiency (FA2D)12 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels.
See also OMIM:613679| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_055232 | 72 | E → G in FA2D; Shanghai. 1 Publication | 1 | |
| Natural variantiVAR_006711 | 200 | E → K in FA2D; prothrombin type 3; variant confirmed at protein level. 2 PublicationsCorresponds to variant dbSNP:rs62623459EnsemblClinVar. | 1 | |
| Natural variantiVAR_006712 | 314 | R → C in FA2D; Barcelona/Madrid. 1 PublicationCorresponds to variant dbSNP:rs121918477EnsemblClinVar. | 1 | |
| Natural variantiVAR_006713 | 314 | R → H in FA2D; Padua-1. 1 PublicationCorresponds to variant dbSNP:rs754231232Ensembl. | 1 | |
| Natural variantiVAR_006714 | 380 | M → T in FA2D; Himi-1. 1 PublicationCorresponds to variant dbSNP:rs121918481EnsemblClinVar. | 1 | |
| Natural variantiVAR_006715 | 425 | R → C in FA2D; Quick-1. 1 PublicationCorresponds to variant dbSNP:rs121918479EnsemblClinVar. | 1 | |
| Natural variantiVAR_006716 | 431 | R → H in FA2D; Himi-2. 1 PublicationCorresponds to variant dbSNP:rs121918482EnsemblClinVar. | 1 | |
| Natural variantiVAR_006717 | 461 | R → W in FA2D; Tokushima. 3 PublicationsCorresponds to variant dbSNP:rs121918478EnsemblClinVar. | 1 | |
| Natural variantiVAR_006718 | 509 | E → A in FA2D; Salakta/Frankfurt. 2 Publications | 1 | |
| Natural variantiVAR_006719 | 601 | G → V in FA2D; Quick-2. 1 PublicationCorresponds to variant dbSNP:rs121918480EnsemblClinVar. | 1 |
Ischemic stroke (ISCHSTR)1 Publication
Disease susceptibility is associated with variations affecting the gene represented in this entry.
Disease descriptionA stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.
See also OMIM:601367Thrombophilia due to thrombin defect (THPH1)1 Publication
The disease is caused by mutations affecting the gene represented in this entry. A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis.
Disease descriptionA multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation.
See also OMIM:188050Pregnancy loss, recurrent, 2 (RPRGL2)1 Publication
Disease susceptibility is associated with variations affecting the gene represented in this entry.
Disease descriptionA common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.
See also OMIM:614390Pharmaceutical usei
The peptide TP508 also known as Chrysalin (Orthologic) could be used to accelerate repair of both soft and hard tissues.
Keywords - Diseasei
Disease mutation, ThrombophiliaOrganism-specific databases
| DisGeNETi | 2147 |
| GeneReviewsi | F2 |
| MalaCardsi | F2 |
| MIMi | 188050 phenotype 601367 phenotype 613679 phenotype 614390 phenotype |
| OpenTargetsi | ENSG00000180210 |
| Orphaneti | 329217 Cerebral sinovenous thrombosis 325 Congenital factor II deficiency 64738 Non rare thrombophilia |
| PharmGKBi | PA157 |
Chemistry databases
| ChEMBLi | CHEMBL204 |
| DrugBanki | DB07211 (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE DB06850 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide DB07091 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide DB06845 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide DB07088 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide DB07131 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide DB07095 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide DB07897 1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE DB06878 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide DB06947 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide DB06869 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE DB06929 1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB07400 1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE DB04771 1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE DB04772 1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE DB06854 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DB02193 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine DB07277 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE DB07278 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE DB07105 2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE DB07366 2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER DB08254 2-NAPHTHALENESULFONIC ACID DB07718 3-(4-HYDROXY-PHENYL)PYRUVIC ACID DB07639 3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER DB07190 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide DB07508 4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE DB07809 4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE DB08061 4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE DB03136 4-Iodobenzo[B]Thiophene-2-Carboxamidine DB07440 4-TERT-BUTYLBENZENESULFONIC ACID DB07376 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID) DB06861 6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE DB06866 6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID DB06865 6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID DB03865 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine DB07934 [[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE DB08422 [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE DB07659 AC-(D)PHE-PRO-BOROHOMOLYS-OH DB07660 AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH DB07658 AC-(D)PHE-PRO-BOROLYS-OH DB00025 Antihemophilic Factor (Recombinant) DB00278 Argatroban DB08624 BENZOTHIAZOLE DB01766 Beta-(2-Naphthyl)-Alanine DB07083 beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide DB00006 Bivalirudin DB06404 C1 Esterase Inhibitor (Human) DB09228 C1 Esterase Inhibitor (Recombinant) DB00100 Coagulation Factor IX (Recombinant) DB03159 CRA_8696 DB06911 D-leucyl-N-(3-chlorobenzyl)-L-prolinamide DB06996 D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB06919 D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide DB07027 D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide DB07133 D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide DB06841 D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide DB07143 D-phenylalanyl-N-benzyl-L-prolinamide DB07005 D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide DB06695 Dabigatran etexilate DB00055 Drotrecogin alfa DB03847 Gamma-Carboxy-Glutamic Acid DB01767 Hemi-Babim DB00001 Lepirudin DB04136 Lysophosphotidylserine DB00170 Menadione DB06838 methyl L-phenylalaninate DB08187 METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE DB06868 N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide DB06942 N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide DB06936 N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide DB07165 N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE DB06859 N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE DB06853 N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB06858 N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB07279 N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE DB07944 N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE DB01123 Proflavine DB04786 Suramin DB05777 Thrombomodulin Alfa DB04697 TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE DB04898 Ximelagatran DB08152 {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate |
| GuidetoPHARMACOLOGYi | 2362 |
Polymorphism and mutation databases
| BioMutai | F2 |
| DMDMi | 135807 |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Signal peptidei | 1 – 24 | Sequence analysisAdd BLAST | 24 | |
| PropeptideiPRO_0000028159 | 25 – 43 | 2 PublicationsAdd BLAST | 19 | |
| ChainiPRO_0000028160 | 44 – 622 | ProthrombinAdd BLAST | 579 | |
| PeptideiPRO_0000028161 | 44 – 198 | Activation peptide fragment 1Add BLAST | 155 | |
| PeptideiPRO_0000028162 | 199 – 327 | Activation peptide fragment 2Add BLAST | 129 | |
| ChainiPRO_0000028163 | 328 – 363 | Thrombin light chainAdd BLAST | 36 | |
| ChainiPRO_0000028164 | 364 – 622 | Thrombin heavy chainAdd BLAST | 259 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 49 | 4-carboxyglutamatePROSITE-ProRule annotation2 Publications | 1 | |
| Modified residuei | 50 | 4-carboxyglutamatePROSITE-ProRule annotation2 Publications | 1 | |
| Modified residuei | 57 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Modified residuei | 59 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Disulfide bondi | 60 ↔ 65 | |||
| Modified residuei | 62 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Modified residuei | 63 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Modified residuei | 68 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Modified residuei | 69 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Modified residuei | 72 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Modified residuei | 75 | 4-carboxyglutamatePROSITE-ProRule annotation1 Publication | 1 | |
| Disulfide bondi | 90 ↔ 103 | |||
| Disulfide bondi | 108 ↔ 186 | |||
| Glycosylationi | 121 | N-linked (GlcNAc...) (complex) asparagine3 Publications | 1 | |
| Disulfide bondi | 129 ↔ 169 | |||
| Glycosylationi | 143 | N-linked (GlcNAc...) (complex) asparagine3 Publications | 1 | |
| Disulfide bondi | 157 ↔ 181 | |||
| Disulfide bondi | 213 ↔ 291 | |||
| Disulfide bondi | 234 ↔ 274 | |||
| Disulfide bondi | 262 ↔ 286 | |||
| Disulfide bondi | 336 ↔ 482 | Interchain (between light and heavy chains) | ||
| Disulfide bondi | 391 ↔ 407 | |||
| Glycosylationi | 416 | N-linked (GlcNAc...) (complex) asparagine5 Publications | 1 | |
| Disulfide bondi | 536 ↔ 550 | By similarity | ||
| Disulfide bondi | 564 ↔ 594 | By similarity |
Post-translational modificationi
The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin K-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin.2 Publications
N-glycosylated. N-glycan heterogeneity at Asn-121: Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).7 Publications
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sitei | 198 – 199 | Cleavage; by thrombin | 2 | |
| Sitei | 327 – 328 | Cleavage; by factor Xa | 2 | |
| Sitei | 363 – 364 | Cleavage; by factor Xa | 2 |
Keywords - PTMi
Cleavage on pair of basic residues, Disulfide bond, Gamma-carboxyglutamic acid, Glycoprotein, ZymogenProteomic databases
| EPDi | P00734 |
| MaxQBi | P00734 |
| PaxDbi | P00734 |
| PeptideAtlasi | P00734 |
| PRIDEi | P00734 |
| ProteomicsDBi | 51269 |
| TopDownProteomicsi | P00734 |
2D gel databases
| SWISS-2DPAGEi | P00734 |
PTM databases
| GlyConnecti | 518 |
| iPTMneti | P00734 |
| PhosphoSitePlusi | P00734 |
| UniCarbKBi | P00734 |
Miscellaneous databases
| PMAP-CutDBi | P00734 |
Expressioni
Tissue specificityi
Expressed by the liver and secreted in plasma.
Gene expression databases
| Bgeei | ENSG00000180210 Expressed in 66 organ(s), highest expression level in right lobe of liver |
| CleanExi | HS_F2 |
| ExpressionAtlasi | P00734 baseline and differential |
| Genevisiblei | P00734 HS |
Organism-specific databases
| HPAi | CAB016780 CAB018650 HPA051476 HPA054698 |
Interactioni
Subunit structurei
Heterodimer (named alpha-thrombin) of a light and a heavy chain; disulfide-linked. Forms a heterodimer with SERPINA5.7 Publications
Binary interactionsi
GO - Molecular functioni
- growth factor activity Source: BHF-UCL
- signaling receptor binding Source: UniProtKB
Protein-protein interaction databases
| BioGridi | 108447, 16 interactors |
| DIPi | DIP-6115N |
| IntActi | P00734, 13 interactors |
| STRINGi | 9606.ENSP00000308541 |
Chemistry databases
| BindingDBi | P00734 |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details3D structure databases
| ProteinModelPortali | P00734 |
| SMRi | P00734 |
| ModBasei | Search... |
| MobiDBi | Search... |
Miscellaneous databases
| EvolutionaryTracei | P00734 |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 44 – 89 | GlaPROSITE-ProRule annotationAdd BLAST | 46 | |
| Domaini | 108 – 186 | Kringle 1PROSITE-ProRule annotationAdd BLAST | 79 | |
| Domaini | 213 – 291 | Kringle 2PROSITE-ProRule annotationAdd BLAST | 79 | |
| Domaini | 364 – 618 | Peptidase S1PROSITE-ProRule annotationAdd BLAST | 255 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 551 – 573 | High affinity receptor-binding region which is also known as the TP508 peptideAdd BLAST | 23 |
Sequence similaritiesi
Belongs to the peptidase S1 family.PROSITE-ProRule annotation
Keywords - Domaini
Kringle, Repeat, SignalPhylogenomic databases
| eggNOGi | ENOG410IKPN Eukaryota COG5640 LUCA |
| GeneTreei | ENSGT00760000119133 |
| HOVERGENi | HBG108381 |
| InParanoidi | P00734 |
| KOi | K01313 |
| OMAi | HPVCLPD |
| OrthoDBi | EOG091G0AH5 |
| PhylomeDBi | P00734 |
| TreeFami | TF327329 |
Family and domain databases
| CDDi | cd00108 KR, 2 hits cd00190 Tryp_SPc, 1 hit |
| Gene3Di | 2.40.20.10, 2 hits 4.10.140.10, 1 hit |
| InterProi | View protein in InterPro IPR035972 GLA-like_dom_SF IPR000294 GLA_domain IPR000001 Kringle IPR013806 Kringle-like IPR018056 Kringle_CS IPR038178 Kringle_sf IPR009003 Peptidase_S1_PA IPR001314 Peptidase_S1A IPR003966 Prothrombin/thrombin IPR018992 Thrombin_light_chain IPR037111 Thrombin_light_chain_sf IPR001254 Trypsin_dom IPR018114 TRYPSIN_HIS IPR033116 TRYPSIN_SER |
| PANTHERi | PTHR24254:SF10 PTHR24254:SF10, 1 hit |
| Pfami | View protein in Pfam PF00594 Gla, 1 hit PF00051 Kringle, 2 hits PF09396 Thrombin_light, 1 hit PF00089 Trypsin, 1 hit |
| PIRSFi | PIRSF001149 Thrombin, 1 hit |
| PRINTSi | PR00722 CHYMOTRYPSIN PR00001 GLABLOOD PR01505 PROTHROMBIN |
| SMARTi | View protein in SMART SM00069 GLA, 1 hit SM00130 KR, 2 hits SM00020 Tryp_SPc, 1 hit |
| SUPFAMi | SSF50494 SSF50494, 1 hit SSF57440 SSF57440, 2 hits SSF57630 SSF57630, 1 hit |
| PROSITEi | View protein in PROSITE PS00011 GLA_1, 1 hit PS50998 GLA_2, 1 hit PS00021 KRINGLE_1, 2 hits PS50070 KRINGLE_2, 2 hits PS50240 TRYPSIN_DOM, 1 hit PS00134 TRYPSIN_HIS, 1 hit PS00135 TRYPSIN_SER, 1 hit |
Sequence (1+)i
Sequence statusi: Complete.
Sequence processingi: The displayed sequence is further processed into a mature form.
This entry has 1 described isoform and 2 potential isoforms that are computationally mapped.iShow all
P00734-1 [UniParc]FASTAAdd to basket
10 20 30 40 50
MAHVRGLQLP GCLALAALCS LVHSQHVFLA PQQARSLLQR VRRANTFLEE
60 70 80 90 100
VRKGNLEREC VEETCSYEEA FEALESSTAT DVFWAKYTAC ETARTPRDKL
110 120 130 140 150
AACLEGNCAE GLGTNYRGHV NITRSGIECQ LWRSRYPHKP EINSTTHPGA
160 170 180 190 200
DLQENFCRNP DSSTTGPWCY TTDPTVRRQE CSIPVCGQDQ VTVAMTPRSE
210 220 230 240 250
GSSVNLSPPL EQCVPDRGQQ YQGRLAVTTH GLPCLAWASA QAKALSKHQD
260 270 280 290 300
FNSAVQLVEN FCRNPDGDEE GVWCYVAGKP GDFGYCDLNY CEEAVEEETG
310 320 330 340 350
DGLDEDSDRA IEGRTATSEY QTFFNPRTFG SGEADCGLRP LFEKKSLEDK
360 370 380 390 400
TERELLESYI DGRIVEGSDA EIGMSPWQVM LFRKSPQELL CGASLISDRW
410 420 430 440 450
VLTAAHCLLY PPWDKNFTEN DLLVRIGKHS RTRYERNIEK ISMLEKIYIH
460 470 480 490 500
PRYNWRENLD RDIALMKLKK PVAFSDYIHP VCLPDRETAA SLLQAGYKGR
510 520 530 540 550
VTGWGNLKET WTANVGKGQP SVLQVVNLPI VERPVCKDST RIRITDNMFC
560 570 580 590 600
AGYKPDEGKR GDACEGDSGG PFVMKSPFNN RWYQMGIVSW GEGCDRDGKY
610 620
GFYTHVFRLK KWIQKVIDQF GE
Computationally mapped potential isoform sequencesi
There are 2 potential isoforms mapped to this entry.BLASTAlignShow allAdd to basket| E9PIT3 | E9PIT3_HUMAN | Prothrombin | F2 | 583 | Annotation score: | ||
| C9JV37 | C9JV37_HUMAN | Prothrombin | F2 | 324 | Annotation score: |
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 9 – 25 | Missing in BAG64719 (PubMed:14702039).CuratedAdd BLAST | 17 | |
| Sequence conflicti | 66 | S → N in BAD96497 (Ref. 4) Curated | 1 | |
| Sequence conflicti | 119 | H → N AA sequence (PubMed:266717).Curated | 1 | |
| Sequence conflicti | 121 | N → S AA sequence (PubMed:266717).Curated | 1 | |
| Sequence conflicti | 164 | T → I AA sequence (PubMed:266717).Curated | 1 | |
| Sequence conflicti | 164 | T → N in CAA23842 (PubMed:6305407).Curated | 1 | |
| Sequence conflicti | 176 | V → A AA sequence (PubMed:266717).Curated | 1 | |
| Sequence conflicti | 183 | I → T AA sequence (PubMed:266717).Curated | 1 | |
| Sequence conflicti | 194 – 195 | AM → MV AA sequence (PubMed:266717).Curated | 2 | |
| Sequence conflicti | 308 | D → DEE AA sequence (PubMed:266717).Curated | 1 | |
| Sequence conflicti | 335 | D → N AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 337 | G → R in BAD96495 (Ref. 4) Curated | 1 | |
| Sequence conflicti | 349 | D → N AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 369 | D → N AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 398 | D → N AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 414 | D → N AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 485 | D → N AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 494 | Q → G AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 504 | W → Y AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 509 | E → S AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 511 | W → V AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 514 | N → D AA sequence (PubMed:873923).Curated | 1 | |
| Sequence conflicti | 529 – 530 | PI → AL AA sequence (PubMed:873923).Curated | 2 | |
| Sequence conflicti | 590 – 592 | WGE → AGA in AAR08143 (Ref. 11) Curated | 3 |
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_055232 | 72 | E → G in FA2D; Shanghai. 1 Publication | 1 | |
| Natural variantiVAR_011781 | 165 | T → M Polymorphism; confirmed at protein level. 4 PublicationsCorresponds to variant dbSNP:rs5896EnsemblClinVar. | 1 | |
| Natural variantiVAR_006711 | 200 | E → K in FA2D; prothrombin type 3; variant confirmed at protein level. 2 PublicationsCorresponds to variant dbSNP:rs62623459EnsemblClinVar. | 1 | |
| Natural variantiVAR_006712 | 314 | R → C in FA2D; Barcelona/Madrid. 1 PublicationCorresponds to variant dbSNP:rs121918477EnsemblClinVar. | 1 | |
| Natural variantiVAR_006713 | 314 | R → H in FA2D; Padua-1. 1 PublicationCorresponds to variant dbSNP:rs754231232Ensembl. | 1 | |
| Natural variantiVAR_006714 | 380 | M → T in FA2D; Himi-1. 1 PublicationCorresponds to variant dbSNP:rs121918481EnsemblClinVar. | 1 | |
| Natural variantiVAR_011782 | 386 | P → T Polymorphism; confirmed at protein level. 2 PublicationsCorresponds to variant dbSNP:rs5897Ensembl. | 1 | |
| Natural variantiVAR_006715 | 425 | R → C in FA2D; Quick-1. 1 PublicationCorresponds to variant dbSNP:rs121918479EnsemblClinVar. | 1 | |
| Natural variantiVAR_006716 | 431 | R → H in FA2D; Himi-2. 1 PublicationCorresponds to variant dbSNP:rs121918482EnsemblClinVar. | 1 | |
| Natural variantiVAR_006717 | 461 | R → W in FA2D; Tokushima. 3 PublicationsCorresponds to variant dbSNP:rs121918478EnsemblClinVar. | 1 | |
| Natural variantiVAR_006718 | 509 | E → A in FA2D; Salakta/Frankfurt. 2 Publications | 1 | |
| Natural variantiVAR_068913 | 532 | E → Q Polymorphism; confirmed at protein level. 2 Publications | 1 | |
| Natural variantiVAR_006719 | 601 | G → V in FA2D; Quick-2. 1 PublicationCorresponds to variant dbSNP:rs121918480EnsemblClinVar. | 1 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | M17262 Genomic DNA Translation: AAC63054.1 AJ972449 mRNA Translation: CAJ01369.1 AK303747 mRNA Translation: BAG64719.1 AK312965 mRNA Translation: BAG35804.1 AK222775 mRNA Translation: BAD96495.1 AK222777 mRNA Translation: BAD96497.1 AF478696 Genomic DNA Translation: AAL77436.1 BC051332 mRNA Translation: AAH51332.1 V00595 mRNA Translation: CAA23842.1 AY344794 mRNA Translation: AAR08143.1 |
| CCDSi | CCDS31476.1 |
| PIRi | A29351 TBHU |
| RefSeqi | NP_000497.1, NM_000506.4 NP_001298186.1, NM_001311257.1 |
| UniGenei | Hs.655207 |
Genome annotation databases
| Ensembli | ENST00000311907; ENSP00000308541; ENSG00000180210 |
| GeneIDi | 2147 |
| KEGGi | hsa:2147 |
| UCSCi | uc001ndf.5 human |
Keywords - Coding sequence diversityi
PolymorphismSimilar proteinsi
Cross-referencesi
Web resourcesi
| Wikipedia Thrombin entry |
| SeattleSNPs |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | M17262 Genomic DNA Translation: AAC63054.1 AJ972449 mRNA Translation: CAJ01369.1 AK303747 mRNA Translation: BAG64719.1 AK312965 mRNA Translation: BAG35804.1 AK222775 mRNA Translation: BAD96495.1 AK222777 mRNA Translation: BAD96497.1 AF478696 Genomic DNA Translation: AAL77436.1 BC051332 mRNA Translation: AAH51332.1 V00595 mRNA Translation: CAA23842.1 AY344794 mRNA Translation: AAR08143.1 |
| CCDSi | CCDS31476.1 |
| PIRi | A29351 TBHU |
| RefSeqi | NP_000497.1, NM_000506.4 NP_001298186.1, NM_001311257.1 |
| UniGenei | Hs.655207 |
3D structure databases
Protein-protein interaction databases
| BioGridi | 108447, 16 interactors |
| DIPi | DIP-6115N |
| IntActi | P00734, 13 interactors |
| STRINGi | 9606.ENSP00000308541 |
Chemistry databases
| BindingDBi | P00734 |
| ChEMBLi | CHEMBL204 |
| DrugBanki | DB07211 (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE DB06850 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide DB07091 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide DB06845 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide DB07088 (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide DB07131 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide DB07095 (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide DB07897 1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE DB06878 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide DB06947 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide DB06869 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE DB06929 1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB07400 1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE DB04771 1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE DB04772 1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE DB06854 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DB02193 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine DB07277 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE DB07278 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE DB07105 2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE DB07366 2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER DB08254 2-NAPHTHALENESULFONIC ACID DB07718 3-(4-HYDROXY-PHENYL)PYRUVIC ACID DB07639 3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER DB07190 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide DB07508 4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE DB07809 4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE DB08061 4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE DB03136 4-Iodobenzo[B]Thiophene-2-Carboxamidine DB07440 4-TERT-BUTYLBENZENESULFONIC ACID DB07376 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID) DB06861 6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE DB06866 6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID DB06865 6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID DB03865 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine DB07934 [[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE DB08422 [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE DB07659 AC-(D)PHE-PRO-BOROHOMOLYS-OH DB07660 AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH DB07658 AC-(D)PHE-PRO-BOROLYS-OH DB00025 Antihemophilic Factor (Recombinant) DB00278 Argatroban DB08624 BENZOTHIAZOLE DB01766 Beta-(2-Naphthyl)-Alanine DB07083 beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide DB00006 Bivalirudin DB06404 C1 Esterase Inhibitor (Human) DB09228 C1 Esterase Inhibitor (Recombinant) DB00100 Coagulation Factor IX (Recombinant) DB03159 CRA_8696 DB06911 D-leucyl-N-(3-chlorobenzyl)-L-prolinamide DB06996 D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB06919 D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide DB07027 D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide DB07133 D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide DB06841 D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide DB07143 D-phenylalanyl-N-benzyl-L-prolinamide DB07005 D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide DB06695 Dabigatran etexilate DB00055 Drotrecogin alfa DB03847 Gamma-Carboxy-Glutamic Acid DB01767 Hemi-Babim DB00001 Lepirudin DB04136 Lysophosphotidylserine DB00170 Menadione DB06838 methyl L-phenylalaninate DB08187 METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE DB06868 N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide DB06942 N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide DB06936 N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide DB07165 N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE DB06859 N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE DB06853 N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB06858 N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide DB07279 N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE DB07944 N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE DB01123 Proflavine DB04786 Suramin DB05777 Thrombomodulin Alfa DB04697 TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE DB04898 Ximelagatran DB08152 {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate |
| GuidetoPHARMACOLOGYi | 2362 |
Protein family/group databases
| MEROPSi | S01.217 |
| MoonDBi | P00734 Curated |
PTM databases
| GlyConnecti | 518 |
| iPTMneti | P00734 |
| PhosphoSitePlusi | P00734 |
| UniCarbKBi | P00734 |
Polymorphism and mutation databases
| BioMutai | F2 |
| DMDMi | 135807 |
2D gel databases
| SWISS-2DPAGEi | P00734 |
Proteomic databases
| EPDi | P00734 |
| MaxQBi | P00734 |
| PaxDbi | P00734 |
| PeptideAtlasi | P00734 |
| PRIDEi | P00734 |
| ProteomicsDBi | 51269 |
| TopDownProteomicsi | P00734 |
Protocols and materials databases
| DNASUi | 2147 |
| Structural Biology Knowledgebase | Search... |
Genome annotation databases
| Ensembli | ENST00000311907; ENSP00000308541; ENSG00000180210 |
| GeneIDi | 2147 |
| KEGGi | hsa:2147 |
| UCSCi | uc001ndf.5 human |
Organism-specific databases
| CTDi | 2147 |
| DisGeNETi | 2147 |
| EuPathDBi | HostDB:ENSG00000180210.14 |
| GeneCardsi | F2 |
| GeneReviewsi | F2 |
| H-InvDBi | HIX0026188 |
| HGNCi | HGNC:3535 F2 |
| HPAi | CAB016780 CAB018650 HPA051476 HPA054698 |
| MalaCardsi | F2 |
| MIMi | 176930 gene 188050 phenotype 601367 phenotype 613679 phenotype 614390 phenotype |
| neXtProti | NX_P00734 |
| OpenTargetsi | ENSG00000180210 |
| Orphaneti | 329217 Cerebral sinovenous thrombosis 325 Congenital factor II deficiency 64738 Non rare thrombophilia |
| PharmGKBi | PA157 |
| GenAtlasi | Search... |
Phylogenomic databases
| eggNOGi | ENOG410IKPN Eukaryota COG5640 LUCA |
| GeneTreei | ENSGT00760000119133 |
| HOVERGENi | HBG108381 |
| InParanoidi | P00734 |
| KOi | K01313 |
| OMAi | HPVCLPD |
| OrthoDBi | EOG091G0AH5 |
| PhylomeDBi | P00734 |
| TreeFami | TF327329 |
Enzyme and pathway databases
| BRENDAi | 3.4.21.5 2681 |
| Reactomei | R-HSA-140837 Intrinsic Pathway of Fibrin Clot Formation R-HSA-140875 Common Pathway of Fibrin Clot Formation R-HSA-159740 Gamma-carboxylation of protein precursors R-HSA-159763 Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159782 Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-202733 Cell surface interactions at the vascular wall R-HSA-375276 Peptide ligand-binding receptors R-HSA-381426 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-416476 G alpha (q) signalling events R-HSA-456926 Thrombin signalling through proteinase activated receptors (PARs) R-HSA-76009 Platelet Aggregation (Plug Formation) R-HSA-977606 Regulation of Complement cascade |
| SABIO-RKi | P00734 |
| SIGNORi | P00734 |
Miscellaneous databases
| ChiTaRSi | F2 human |
| EvolutionaryTracei | P00734 |
| GeneWikii | Thrombin |
| GenomeRNAii | 2147 |
| PMAP-CutDBi | P00734 |
| PROi | PR:P00734 |
| SOURCEi | Search... |
Gene expression databases
| Bgeei | ENSG00000180210 Expressed in 66 organ(s), highest expression level in right lobe of liver |
| CleanExi | HS_F2 |
| ExpressionAtlasi | P00734 baseline and differential |
| Genevisiblei | P00734 HS |
Family and domain databases
| CDDi | cd00108 KR, 2 hits cd00190 Tryp_SPc, 1 hit |
| Gene3Di | 2.40.20.10, 2 hits 4.10.140.10, 1 hit |
| InterProi | View protein in InterPro IPR035972 GLA-like_dom_SF IPR000294 GLA_domain IPR000001 Kringle IPR013806 Kringle-like IPR018056 Kringle_CS IPR038178 Kringle_sf IPR009003 Peptidase_S1_PA IPR001314 Peptidase_S1A IPR003966 Prothrombin/thrombin IPR018992 Thrombin_light_chain IPR037111 Thrombin_light_chain_sf IPR001254 Trypsin_dom IPR018114 TRYPSIN_HIS IPR033116 TRYPSIN_SER |
| PANTHERi | PTHR24254:SF10 PTHR24254:SF10, 1 hit |
| Pfami | View protein in Pfam PF00594 Gla, 1 hit PF00051 Kringle, 2 hits PF09396 Thrombin_light, 1 hit PF00089 Trypsin, 1 hit |
| PIRSFi | PIRSF001149 Thrombin, 1 hit |
| PRINTSi | PR00722 CHYMOTRYPSIN PR00001 GLABLOOD PR01505 PROTHROMBIN |
| SMARTi | View protein in SMART SM00069 GLA, 1 hit SM00130 KR, 2 hits SM00020 Tryp_SPc, 1 hit |
| SUPFAMi | SSF50494 SSF50494, 1 hit SSF57440 SSF57440, 2 hits SSF57630 SSF57630, 1 hit |
| PROSITEi | View protein in PROSITE PS00011 GLA_1, 1 hit PS50998 GLA_2, 1 hit PS00021 KRINGLE_1, 2 hits PS50070 KRINGLE_2, 2 hits PS50240 TRYPSIN_DOM, 1 hit PS00134 TRYPSIN_HIS, 1 hit PS00135 TRYPSIN_SER, 1 hit |
| ProtoNeti | Search... |
Entry informationi
| Entry namei | THRB_HUMAN | |
| Accessioni | P00734Primary (citable) accession number: P00734 Secondary accession number(s): B2R7F7 Q9UCA1 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | July 21, 1986 |
| Last sequence update: | January 1, 1990 | |
| Last modified: | September 12, 2018 | |
| This is version 244 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |



